CEPHEID (CPHD) has 3,869,504 shares of shorts outstanding as on August 15, 2016, with 5 days left to cover or roll them over. On Jul 29, 2016, the open interest of short positions was 3,946,142 shares. The stock has a decent trading volume of 731,740 shares daily. The marginal decrease in the short positions is by -1.9%, which amounts to -76,638 shares. Short positions are 5.4% of the available float. The short interest information was released on Wednesday Aug 24th after the market close.
CEPHEID (NASDAQ:CPHD): The stock opened at $36.59 on Wednesday but the bulls could not build on the opening and the stock topped out at $36.60 for the day. The stock traded down to $34.75 during the day, due to lack of any buying support eventually closed down at $34.87 with a loss of -4.44% for the day. The stock had closed at $36.49 on the previous day. The total traded volume was 565,874 shares.
In a related news, Campbell Scott A., officer (Corporate VP & CRO) of Cepheid, unloaded 287 shares at an average price of $36.16 on August 17, 2016. The total amount of the transaction was worth $10,378, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the clinical market and non-clinical markets. Its systems enable molecular testing for organisms and genetic-based diseases. Molecular testing involves various time-intensive steps, including sample preparation, DNA amplification and detection. The Companys systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to DNA amplification and detection, serves reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.